Takeuchi K, Kato S, Nishiwaki H, Hirata T
Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Japan.
J Gastroenterol Hepatol. 1997 May;12(5):360-7. doi: 10.1111/j.1440-1746.1997.tb00443.x.
Pathogenesis of gastric damage induced by non-steroidal anti-inflammatory drugs (NSAID) involves multiple elements, such as deficiency of prostaglandins (PG), gastric hypermotility, neutrophil activation and luminal acid. The present study was performed to examine the effects of these elements, either alone or in combination, on the rat gastric mucosa and investigate which element is most closely associated with the gastric ulcerogenic response to NSAID. The following treatments were used to express various pathogenic elements: (i) a low dose of indomethacin (IM) to cause PG deficiency; (ii) 2-deoxy-D-glucose (2DG) to induce gastric hypermotility and acid secretion; (iii) histamine to induce acid hypersecretion; and (iv) n-formyl-Met-Leu-Phe (fMLP) to elicit neutrophil activation. When rats fasted for 18 h were subjected to each treatment alone, only 2DG caused slight macroscopic damage in the gastric mucosa within 4 h. Indomethacin showed over 90% inhibition of mucosal PG generation and fMLP increased myeloperoxidase activity four-fold greater than normal values, yet either of these treatments alone did not cause any damage in the stomach. However, the combination of IM with 2DG or His provoked severe lesions in the stomach or the duodenum, respectively, while fMLP did not modify or potentiate the mucosal ulcerogenic response to other treatments. We conclude that among various pathogenic elements only gastric hypermotility is sufficient, by itself, to induce mild damage in the mucosa, that PG deficiency may be critical in the increase of mucosal susceptibility to injury and that neutrophil activation alone is not ulcerogenic in the gastric mucosa nor does it potentiate the ulcerogenic effect of other elements. Luminal acid may be a prerequisite for later extension of damage to severe lesions.
非甾体抗炎药(NSAID)所致胃损伤的发病机制涉及多个因素,如前列腺素(PG)缺乏、胃动力亢进、中性粒细胞活化和管腔内酸。本研究旨在考察这些因素单独或联合作用对大鼠胃黏膜的影响,并探究哪个因素与NSAID引起的胃溃疡形成反应关系最为密切。采用以下处理来体现各种致病因素:(i)低剂量吲哚美辛(IM)以造成PG缺乏;(ii)2-脱氧-D-葡萄糖(2DG)以诱导胃动力亢进和胃酸分泌;(iii)组胺以诱导胃酸分泌过多;(iv)N-甲酰甲硫氨酰亮氨酰苯丙氨酸(fMLP)以引发中性粒细胞活化。当禁食18小时的大鼠单独接受每种处理时,仅2DG在4小时内导致胃黏膜出现轻微的肉眼可见损伤。吲哚美辛使黏膜PG生成受到超过90%的抑制,fMLP使髓过氧化物酶活性比正常值增加了四倍,但这两种处理单独进行时均未对胃造成任何损伤。然而,IM与2DG或组胺联合分别在胃或十二指肠引发了严重病变,而fMLP并未改变或增强对其他处理的黏膜溃疡形成反应。我们得出结论,在各种致病因素中,仅胃动力亢进本身就足以诱导黏膜出现轻度损伤,PG缺乏可能在增加黏膜对损伤的易感性方面起关键作用,单独的中性粒细胞活化在胃黏膜中不会引发溃疡,也不会增强其他因素的致溃疡作用。管腔内酸可能是损伤后期扩展为严重病变的一个先决条件。